Publications

About this release This is the second release from Public Health Scotland (PHS) providing information on pregnancy chromosomal condition screening for Down's syndrome, Edwards'...

The aim of this work was to capture real-world evidence from Scotland on the use of maintenance poly (ADP-ribose) polymerase inhibitor (PARPi) Systemic Anti-Cancer Therapy (SACT) of adult patients with advanced high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, following completion of first-line platinum-based chemotherapy. The Scottish Medicines Consortium (SMC) requested this work which describes current SACT use in this population. This work will assist SMC members when considering submissions for rucaparib (SMC2799).

A&E activity: week ending 15 June 2025...

About this release This monthly publication by Public Health Scotland (PHS) presents the latest available weekly management information on the total number of people waiting for an...

About this release This data release by Public Health Scotland (PHS) includes summary reports detailing analyses carried out by the Scottish Burden of Disease (SBoD)study to...

This release by Public Health Scotland (PHS) presents performance against the National Melanoma Cancer Quality Performance Indicators (QPIs) in the Cancer QPIs dashboard held within the Scottish Cancer Registry and Intelligence Service (SCRIS).

A quarterly update of immunisation uptake rates for children in Scotland at 12 months, 24 months, five years and six years of age.

About this release This release by Public Health Scotland (PHS) supplements the Alcohol Consumption and Harms Dashboard (ACHD) with a new dataset of alcohol retail sales and...

Waiting times for people accessing drug and alcohol treatment services

How long patients wait for a first clinical appointment for MSK services